Personalized therapy for mycophenolate: consensus report by the international association of therapeutic drug monitoring and clinical toxicology

S Bergan, M Brunet, DA Hesselink… - Therapeutic drug …, 2021 - journals.lww.com
When mycophenolic acid (MPA) was originally marketed for immunosuppressive therapy,
fixed doses were recommended by the manufacturer. Awareness of the potential for a more …

New developments in the management of cytomegalovirus infection after solid organ transplantation

AJ Eid, RR Razonable - Drugs, 2010 - Springer
Despite remarkable advances in the diagnostic and therapeutic modalities for its
management, cytomegalovirus (CMV) remains one of the most important pathogens …

[HTML][HTML] New treatment options for refractory/resistant CMV infection

CS Walti, N Khanna, RK Avery… - Transplant …, 2023 - frontierspartnerships.org
Despite advances in monitoring and treatment, cytomegalovirus (CMV) infections remain
one of the most common complications after solid organ transplant (SOT). CMV infection …

Cytomegalovirus infection and disease in the new era of immunosuppression following solid organ transplantation

RA Fisher - Transplant Infectious Disease, 2009 - Wiley Online Library
As the most prevalent pathogen among transplant patients, cytomegalovirus (CMV) affects
up to three‐quarters of all solid organ transplant recipients. While we have made great …

Prevalence of Cryptosporidium, Blastocystis, and other opportunistic infections in patients with primary and acquired immunodeficiency

M Bednarska, I Jankowska, A Pawelas… - Parasitology …, 2018 - Springer
Intestinal opportunistic infections are often caused by unicellular parasites. Individuals with
decreased immunity are particularly susceptible to infection by said microorganisms, and …

The inflammatory state is a risk factor for cardiovascular disease and graft fibrosis in kidney transplantation

C Ponticelli, MR Campise - Kidney International, 2021 - Elsevier
Several factors, such as donor brain death, ischemia-reperfusion injury, rejection, infection,
and chronic allograft dysfunction, may induce an inflammatory state in kidney …

Everolimus is associated with a reduced incidence of cytomegalovirus infection following de novo cardiac transplantation

J Kobashigawa, H Ross, C Bara… - Transplant Infectious …, 2013 - Wiley Online Library
Background Cytomegalovirus (CMV) causes several complications following cardiac
transplantation including cardiac allograft vasculopathy. Previous studies suggested that …

[HTML][HTML] Risk factors for hospitalization for bacterial or viral infection in renal transplant recipients-an analysis of USRDS data

VR Dharnidharka, LY Agodoa, KC Abbott - American journal of …, 2007 - Elsevier
We previously showed that children are more likely to develop viral infections post‐kidney
transplant while adults are more likely to develop bacterial infections. In this study we …

Impact of GVHD prophylaxis on CMV reactivation and disease after HLA-matched peripheral blood stem cell transplantation

M Ueda Oshima, H Xie, D Zamora, ME Flowers… - Blood …, 2023 - ashpublications.org
The kinetics of early and late cytomegalovirus (CMV) reactivation after hematopoietic cell
transplantation using various methods of graft-versus-host-disease (GVHD) prophylaxis are …

CMV Viremia is associated with a decreased incidence of BKV reactivation after kidney and kidney-pancreas transplantation

N Elfadawy, SM Flechner, X Liu, J Schold… - …, 2013 - journals.lww.com
Background Cytomegalovirus (CMV) and BK virus (BKV) infections can cause significant
morbidity after kidney and kidney-pancreas transplant. There are limited data on the …